US Computed Tomography (CT) Market Overview
The US Computed Tomography (CT) Market was valued at USD 1.45 Billion in 2024. The Computed Tomography (CT) Market industry is projected to grow from USD 1.56 Billion in 2025 to USD 2.73 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.07% during the forecast period (2025-2035).
The increasing incidences of chronic diseases and expansion of CT in trauma & emergency care are driving the growth of the Computed Tomography (CT) Market.
As per the Analyst at MRFR, the significant investments in healthcare infrastructure are driving the US Computed Tomography (CT) Market. Furthermore, increasing incidence of chronic diseases, cancer, cardiovascular diseases, and neurological disorders are increasing the demand for imaging procedures fueling the growth of the market.Â
However, the high cost of CT scanners and reimbursement challenges are restraining the growth of the US Computed Tomography (CT) Market. Additionally, the Growing Demand for Portable & Point-of-Care CT Scanners and AI Integration in CT Imaging will provide growth opportunities for the market in the future.
FIGURE 1: US COMPUTED TOMOGRAPHY (CT) MARKET VALUE (2019-2035) USD BILLION

 Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
US Computed Tomography (CT) Market Opportunity
AI INTEGRATION IN CT IMAGING
AI integration in CT imaging is expected to create significant opportunities in the US CT scan market by enhancing diagnostic capabilities, optimizing workflows, and improving patient outcomes. The adoption of AI-powered algorithms enables radiologists to detect subtle abnormalities, such as tumors, fractures, and organ anomalies, with higher accuracy and speed. This is particularly beneficial in critical care settings, where rapid and precise diagnosis is crucial.Â
By assisting in automated image interpretation and real-time analysis, AI reduces human error and improves the consistency of diagnoses, contributing to better clinical decision-making and enhanced patient care. One of the key opportunities AI brings is the ability to perform low-dose CT scans without compromising image quality. As radiation exposure remains a concern, AI helps optimize scan protocols, making CT safer for patients, especially in pediatric and geriatric populations. AI can also enhance workflow efficiency by reducing the time needed for image processing and interpretation, thus allowing radiologists to handle more cases in less time.
US Computed Tomography (CT) Market Segment Insights:
Computed Tomography (CT) by Type Insights
Based on Type, the US computed tomography (CT) market has been segmented conventional scanners and cone beam scanners. The conventional scanners are further bifurcated into low slice, medium slice, and high slice. The Conventional Scanners segment dominated the US market in 2024, while the Cone Beam Scanners segment is projected to be the fastest–growing segment during the forecast period.Â
The conventional computed tomography (CT) scanners market in the US is an important component of the larger medical imaging market, with a wide range of scanner models and applications. These scanners are critical in identifying a wide range of medical illnesses, including trauma, cancer, cardiovascular disease, and neurological disorders.Â
CT scanners are generally classified into three different types based on the number of slices they can collect per rotation: low slice, medium slice, and high slice CT scanners. Each type has various advantages depending on the clinical needs, such as diagnostic precision, scan time, and cost efficiency.
FIGURE 2: US COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY TYPE 2024 AND 2035 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Computed Tomography (CT) by Application Insights
Based on Application, the US computed tomography (CT) market has been segmented oncology, neurology, cardiovascular, musculoskeletal, abdominal & pelvic, and others. The Oncology segment dominated the US market in 2024, while the Neurology segment is projected to be the fastest–growing segment during the forecast period. The oncology segment of the US computed tomography (CT) market is an important part of cancer diagnosis, staging, and treatment planning.Â
CT scans are critical for the early identification of several cancers, including lungs, colorectal, liver, and pancreatic cancer. According to the American Cancer Society, cancer is the second biggest cause of death in the United States, with an estimated 2,041,910 new cases in 2025. This increased cancer burden increases the demand for advanced imaging technology, such as CT scanners, in oncological settings. CT scans are commonly used in cancer staging because they provide precise imaging that aids in determining tumor size, location, and extent.Â
This is essential in developing treatment plans. Contrast-enhanced CT is exceptionally efficient at visualizing blood arteries and tumor tissues, giving physicians a complete picture of the cancer's characteristics. Furthermore, CT plays an important role in radiation therapy planning, ensuring that radiation is delivered precisely to target malignancies while avoiding damage to surrounding healthy tissues.
Computed Tomography (CT) by End-User Insights
Based on end user, the US computed tomography (CT) market has been segmented hospitals, specialty centers, and diagnostic and imaging centers.  The Hospitals segment dominated the US market in 2024, while the Diagnostic and Imaging Center segment is projected to be the fastest–growing segment during the forecast period. Hospitals account for a major portion of the computed tomography (CT) market in the US due to their prominent position in diagnostic imaging and patient care.Â
CT scans are commonly used in hospitals to diagnose a wide range of diseases, including trauma, cardiovascular disease, oncological disorders, and neurological disorders. According to the American Hospital Association (AHA), hospitals are increasingly using advanced CT technologies, such as multi-slice CT and high-definition imaging systems, to improve diagnostic capabilities and patient outcomes.Â
The rising prevalence of chronic diseases such as heart disease, cancer, and stroke are a major driver of CT use in hospitals, where prompt and precise imaging is critical for optimal treatment planning. Furthermore, emergency departments (EDs) in hospitals rely extensively on CT scans for rapid assessment of traumatic injuries, internal bleeding, and organ damage since they allow for speedy, non-invasive diagnosis. The use of AI-based software in CT imaging is also gaining popularity in hospitals, allowing for faster and more accurate interpretations.
Computed Tomography (CT) by Distribution Channel Insights
Based on distribution channel, the US computed tomography (CT) market has been segmented into online and offline. The Offline Channels segment dominated the US market in 2024, while the Online Channels segment is projected to be the fastest–growing segment during the forecast period. The offline distribution channel segment of the US computed tomography (CT) market is dominant, especially among large hospitals, diagnostic centers, and specialized healthcare institutions.Â
This conventional distribution approach incorporates direct sales via distributors, dealers, and medical equipment salespeople, with specialized services and hands-on support. Leading manufacturers such as GE Healthcare, Philips Healthcare, and Siemens Healthineers work closely with local distributors to ensure that consumers receive technical assistance, installation, training, and after-sales services. The offline model is essential when purchasing high-cost equipment such as multi-slice CT scanners, which frequently necessitate a thorough evaluation of the healthcare provider's requirements.
Construction Regional Insights
Based on region, the US computed tomography (CT) market has been segmented into Northeast, Midwest, South, and West. The South dominated the global market in 2024, while the West projected to be the fastest–growing segment during the forecast period. The South US, encompassing states such as Texas, Florida, Georgia, and the rest of the South, is important to the US computed tomography (CT) industry due to its enormous population, growing healthcare requirements, and expanding medical infrastructure.Â
Texas, with major medical institutes like the MD Anderson Cancer Center in Houston, is the region's leader in advanced CT imaging for oncology, cardiology, and trauma treatment. Similarly, Florida and Georgia have high CT utilization due to rising chronic disease rates, such as heart disease and diabetes, which require regular CT scans for monitoring and diagnosis.Â
Furthermore, Florida's aging population drives up demand for CT-based screening for diseases such as lung cancer and stroke, with hospitals like the Mayo Clinic in Jacksonville investing in cutting-edge multi-slice CT technology. Outpatient diagnostic clinics and mobile CT services are also becoming increasingly common in the southern US, which is making imaging more accessible.
FIGURE 2: US COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY REGION 2024 AND 2035 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
US Computed Tomography (CT) Key Market Players & Competitive Insights
Many global, regional, and local vendors characterize the Computed Tomography (CT) Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.
The major competitors in the market are Siemens HEALTHINEERS Ag, Shimadzu Corporation, Fujifilm Holdings Corporation, Mindray, Canon Medical Systems Corporation, Ge Healthcare, KONINKLIJKE Philips N.V, Stryker, NEUROLOGICA Corp, Carestream Dental LLC are among others. The US Computed Tomography (CT) Market is a consolidated market due to increasing competition, acquisitions, mergers and other strategic market developments and decisions to improve operational effectiveness.
Key Companies in the US Computed Tomography (CT) Market include
- Siemens Healthineers
- Shimadzu Corporation
- Fujifilm Holdings Corporation
- Mindray
- Canon Medical Systems Corporation
- Ge Healthcare
- KONINKLIJKE Philips N.V
- Stryker
- NEUROLOGICA Corp
- Carestream Dental LLC
US Computed Tomography (CT) Market Industry Developments
June 2024: The FDA approved the FUJIFILM Healthcare Americas Corporation 510(k) approval for the FCT iStream, a revolutionary small, 128-slice computed tomography (CT) system. To improve image sharpness, optimize workflow through AI automation, and drastically lower patient dose, the system uses four key patented Fujifilm technologies: HiMAR Plus (High image quality Metal Artifact Reduction), Intelli IPV, SynergyDrive, and IntelliODM.
November 2023: Siemens Healthineers recently launched a new dual-source CT scanner, the Somatom Pro.Pulse, which that the company claims is more accessible to smaller and rural facilities, as well as outpatient diagnostic clinics.
May 2023: Royal Philips, the parent company of Philips Healthcare, launched its AI-powered 32/64-slice CT scanner, the CT 3500, designed to support routine radiology studies and high-volume screening programs. Developed with high throughput in mind, the CT 3500 incorporated advanced image-reconstruction capabilities and workflow-enhancing features to optimize efficiency and diagnostic accuracy.
October 2022: GE HealthCare introduced the Omni Legend, the first system on its all-new, all-digital PET/CT platform. This advanced system featured a new category of digital BGO (dBGO) detector material with a small crystal size, delivering more than twice the sensitivity of previous digital scanners. It enabled faster total scan times and enhanced small lesion detectability.
US Computed Tomography (CT) Market Segmentation
Computed Tomography (CT) by Type Outlook
-
Conventional Scanners
- Low Slice
- Medium Slice
- High Slice
- Cone Beam Scanners
Computed Tomography (CT) by Application Outlook
- Oncology
- Neurology
- Cardiovascular
- Musculoskeletal
- Abdominal and Pelvic
- Others
Computed Tomography (CT) by End User Outlook
- Hospitals
- Specialty Centers
- Diagnostic and Imaging Center
Computed Tomography (CT) by Distribution Channel Outlook
- Online Channels
- Offline Channels
Computed Tomography (CT) Regional Outlook
-
U.S
- Northeast
- Midwest
- South
- West
Report Attribute/Metric |
Details |
Market Size 2024 |
USD 1.45 Billion |
Market Size 2025 |
USD 1.56 Billion |
Market Size 2035 |
USD 2.73 Billion |
Compound Annual Growth Rate (CAGR) |
7.07% (2025-2035) |
Base Year |
2024 |
Forecast Period |
2025-2035 |
Historical Data |
2019-2023 |
Forecast Units |
Value, Volume (USD Billion) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
By Type, Application, End User, Distribution Channel |
Geographies Covered |
US |
Key Companies Profiled |
Siemens HEALTHINEERS Ag, Shimadzu Corporation, Fujifilm Holdings Corporation, Mindray, Canon Medical Systems Corporation, Ge Healthcare, KONINKLIJKE Philips N.V, Stryker, NEUROLOGICA Corp, Carestream Dental LLCÂ |
Key Market Opportunities |
·        AI integration in CT imaging ·        Growing demand for portable & point-of-care CT scanners |
Key Market Dynamics |
·        Increasing incidences of chronic diseases ·        Expansion of CT in trauma & emergency care |
Frequently Asked Questions (FAQ):
The US Computed Tomography (CT) Market was valued at USD 1.45 Billion in 2024.
The Oncology segment by Application holds the largest market share and grows at a CAGR of 7.39% during the forecast period.
South holds the largest market share in the US Computed Tomography (CT) Market.
Siemens HEALTHINEERS Ag, Shimadzu Corporation, Fujifilm Holdings Corporation, Mindray, Canon Medical Systems Corporation, Ge Healthcare, KONINKLIJKE Philips N.V, Stryker, NEUROLOGICA Corp, Carestream Dental LLC are prominent players in the US Computed Tomography (CT) Market.
The Conventional Scanners segment dominated the market in 2024.